Cancer Drugs Cost Less In Poorer Nations But Not More Affordable, Study Shows
Associated Press: Study: Cancer drugs less affordable in poor nations than U.S.
“Cancer drugs predictably cost much more in the U.S. than in poor countries and even other wealthy nations, but a study shows they are less affordable in some developing countries despite the lower price. Relative to their ability to pay, cancer patients in China and India face much higher prices than wealthier U.S. patients, according to the research released Monday. … The pilot study examined list prices, also called retail prices, and affordability in Australia, China, India, Israel, the United Kingdom, the United States, and South Africa…” (6/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.